ENDRA Life Sciences (NDRA) Gains from Investment Securities (2024 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Gains from Investment Securities of $8857.0 for Q1 2026, up 102.17% year-over-year from $4381.0 in Q1 2025, and up 107.63% quarter-over-quarter from -$116137.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Gains from Investment Securities (2024 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Gains from Investment Securities for 3 consecutive years, with $8857.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 102.17% year-over-year to $8857.0; the TTM figure through Mar 2026 stood at -$248568.0 (changed N/A YoY), while the FY2025 annual figure was -$319537.0, up 90.73% from the prior year.
- Gains from Investment Securities rose to $8857.0 in Q1 2026 per NDRA's latest filing, from -$116137.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $267274.0 in Q3 2025 and bottomed at -$3.3 million in Q3 2024.
- Historically, Gains from Investment Securities has averaged -$616050.8 across 3 years, with a median of -$111022.5 in 2024.
- On a YoY basis, Gains from Investment Securities climbed as much as 108.0% in 2025 and fell as far as 9.66% in 2025.
- ENDRA Life Sciences' Gains from Investment Securities stood at -$105908.0 in 2024, then retreated by 9.66% to -$116137.0 in 2025, then jumped by 107.63% to $8857.0 in 2026.
- Business Quant data shows NDRA's Gains from Investment Securities at $8857.0 in Q1 2026, -$116137.0 in Q4 2025, and $267274.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,857.00 |
| Mar 31, 2026 | 8,857.00 |
| Dec 31, 2025 | -116,137.00 |
| Dec 31, 2025 | -116,137.00 |
| Sep 30, 2025 | 267,274.00 |
| Sep 30, 2025 | 267,274.00 |
| Mar 31, 2025 | -408,562.00 |
| Mar 31, 2025 | -408,562.00 |
| Dec 31, 2024 | -105,908.00 |
| Dec 31, 2024 | -105,908.00 |
| Sep 30, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.34 Mn |